Skip to main content
. 2021 Sep 17;17(5):1138–1145. doi: 10.4103/1673-5374.324854

Figure 2.

Figure 2

Ang-(1–7)/MasR axis is reduced in the substantia nigra of the Parkinson's disease rat model.

(A) The Ang-(1–7) levels in the SN were assessed by enzyme-linked immunosorbent assay. Differences were observed between PD rats and age-matched control rats. (B) The MasR levels in the SN were evaluated by Western blot assay. (C) Quantitative results of MasR expression. Differences were observed between PD rats and age-matched control rats. Data are expressed as the mean ± SD (n = 6; one-way analysis of variance followed by Tukey's post hoc test). ####P < 0.0001, vs. control group. PD: Parkinson's disease; MasR: Mas receptor; SN: substantia nigra; w: weeks.